| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 03/04/2010 | US20100056506 Substituted 2-amino-fused heterocyclic compounds |
| 03/04/2010 | US20100056505 Substituted Pyrazalones |
| 03/04/2010 | US20100056504 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester- introduced phenyl group as substituents |
| 03/04/2010 | US20100056497 Amide derivative |
| 03/04/2010 | US20100056494 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases |
| 03/04/2010 | CA2735373A1 Novel urea and thiourea derivatives |
| 03/04/2010 | CA2734551A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors |
| 03/04/2010 | CA2733648A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 03/03/2010 | EP2159216A1 Ih - Modulators |
| 03/03/2010 | EP2081572B1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 03/03/2010 | EP2018375B1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 03/03/2010 | EP1877405B1 Benzisoxazole piperidine compounds and methods of use thereof |
| 03/03/2010 | EP1789401B1 Isoxazoline derivatives and their use as herbicides |
| 03/03/2010 | EP1749001B1 3-piperidinylisochroman-5-ols as dopamine agonists |
| 03/03/2010 | EP1107964B1 Isoquinoline derivatives with angiogenesis inhibiting activity |
| 03/03/2010 | CN101663297A Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists |
| 03/02/2010 | US7671077 Kits for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis (ALS) |
| 03/02/2010 | US7671073 4-{(1S,2S)-2-Amino-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-methyl-3-oxopropyl}-1-[1,2,4]triazolo[1,5-a]pyridin-6-ylcyclohexanol, bis(trifluoroacetic acid); non-insulin dependent (Type 2) diabetes, hyperglycemia; dipeptidyl peptidase-IV inhibitors |
| 03/02/2010 | US7671063 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors |
| 03/02/2010 | US7671059 (S)-2-Amino-6-benzyl-7-[4-fluoro-2-(2-fluoro-pyridin-3-yl)-phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one;cellular proliferative, viral, autoimmune, cardiovascular, and central nervous system diseases |
| 03/02/2010 | US7671056 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline; central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction |
| 03/02/2010 | US7671049 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases |
| 03/02/2010 | US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV) |
| 03/02/2010 | US7670591 Heteroaryl substituted benzoxazoles |
| 03/02/2010 | CA2394615C Substituted 1,3,4-oxadiazoles and a method of reducing tnf-.alpha. levels |
| 02/25/2010 | WO2010022125A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | WO2010022121A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | WO2010022033A2 Therapeutic substituted pyrroles |
| 02/25/2010 | WO2010021934A2 Azaindole inhibitors of iap |
| 02/25/2010 | WO2010020556A1 New bradykinin b1 antagonists |
| 02/25/2010 | WO2010020522A1 Insecticidal compounds |
| 02/25/2010 | WO2010020521A1 Insceticidal compounds |
| 02/25/2010 | WO2010020305A1 Oxadiazole derivatives for treating diabetes |
| 02/25/2010 | WO2009158571A8 Heteroaryl compounds and uses thereof |
| 02/25/2010 | WO2009149795A3 Heterocyclic cyclopropyl-substituted fxr binding compounds |
| 02/25/2010 | WO2004092124A8 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048891 Metasubstituted thiazolidinones, their manufacture and use as a drug |
| 02/25/2010 | US20100048664 Therapeutic substituted pyrroles |
| 02/25/2010 | US20100048639 Oxadiazole derivates as s1p1 receptor agonists |
| 02/25/2010 | US20100048632 Piperidine GPCR Agonists |
| 02/25/2010 | US20100048631 Piperidine GPCR Agonists |
| 02/25/2010 | US20100048625 Piperidine gpcr agonists |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048587 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings |
| 02/25/2010 | US20100048580 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/25/2010 | US20100048571 Organic Compounds |
| 02/25/2010 | US20100048569 Diazole derivatives |
| 02/25/2010 | US20100048568 Pyrimidine hydrazide compounds as pgds inhibitors |
| 02/25/2010 | US20100048567 Inhibitors of syk and JAK protein kinases |
| 02/25/2010 | US20100048566 Antibacterial quinoline derivatives |
| 02/25/2010 | US20100048565 Benzimidazole derivatives |
| 02/25/2010 | US20100048564 Fused bicyclic heteroaryl derivative |
| 02/25/2010 | US20100048562 Organic compounds |
| 02/25/2010 | US20100048561 Quinazolines for pdk1 inhibition |
| 02/25/2010 | US20100048560 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 02/25/2010 | US20100048556 Quinoxaline derivatives |
| 02/25/2010 | US20100048555 Imidazothiazole derivatives as mark inhibitors |
| 02/25/2010 | US20100048548 Imino-oxazolidines and use thereof |
| 02/25/2010 | US20100048547 Pi 3-kinase inhibitors and methods of their use |
| 02/25/2010 | US20100048543 Pyrimidine compounds having ties (tek) inhibitory activity |
| 02/25/2010 | US20100048540 Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors |
| 02/25/2010 | US20100048539 Compounds and compositions as protein kinase inhibitors |
| 02/25/2010 | DE102008038220A1 Oxadiazolderivate Oxadiazole |
| 02/25/2010 | CA2771226A1 New bradykinin b1 antagonists |
| 02/25/2010 | CA2734859A1 Methods for treating cns disorders |
| 02/25/2010 | CA2734487A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | CA2734486A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | CA2734397A1 Oxadiazole derivatives for the treatment of diabetes |
| 02/25/2010 | CA2733160A1 Insecticidal compounds |
| 02/25/2010 | CA2730357A1 Azaindole inhibitors of iap |
| 02/24/2010 | EP2157090A1 Pyrazinamide compound |
| 02/24/2010 | EP2157085A1 Oxazole, derivatives of tetracyclines |
| 02/24/2010 | EP2155737A1 Gamma secretase modulators |
| 02/24/2010 | EP2155728A2 Heterocyclic indazole derivatives |
| 02/24/2010 | EP2155727A1 N-[6-amino-5-(phenyl)pyrazin-2-yl]-isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain |
| 02/24/2010 | EP2155726A1 Phthalazinone derivatives and their use as medicament to treat cancer |
| 02/24/2010 | EP2155722A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer |
| 02/24/2010 | EP2155718A2 Aryloxazole, aryloxadiazole and benzimidazole derivatives as modulators of somatostatine receptor activity |
| 02/24/2010 | EP2155717A1 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists |
| 02/24/2010 | EP2155716A2 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 02/24/2010 | EP2155689A2 Ccr2 receptor antagonists and uses thereof |
| 02/24/2010 | EP2155687A1 Diacylglycerol acyltransferase inhibitors |
| 02/24/2010 | EP2155683A2 Pyridone derivatives as p38a mapk inhibitors |
| 02/24/2010 | EP2155678A1 New bradykinin b1 antagonists |
| 02/24/2010 | EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
| 02/24/2010 | EP2155194A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/24/2010 | EP1971580B1 Piperazine compounds with a herbicidal action |
| 02/24/2010 | EP1848705B1 Exo- and diastereo- selective syntheses of himbacine analogs |
| 02/24/2010 | EP1742935B1 Polycyclic pyrazines as potassium ion channel modulators |
| 02/24/2010 | EP1625121B1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 02/24/2010 | CN100591679C Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/24/2010 | CN100591666C 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | US7667051 Method of obtaining urethane-protected N-carboxyanhydrides of alpha amino acids |
| 02/23/2010 | US7667041 Cinnamide compound |
| 02/23/2010 | US7666895 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation |
| 02/23/2010 | US7666869 Nitrogen-containing 5-membered ring compound |